MY108437A - Imidazopyridine paf/h1 antagonists - Google Patents

Imidazopyridine paf/h1 antagonists

Info

Publication number
MY108437A
MY108437A MYPI92000223A MYPI19920223A MY108437A MY 108437 A MY108437 A MY 108437A MY PI92000223 A MYPI92000223 A MY PI92000223A MY PI19920223 A MYPI19920223 A MY PI19920223A MY 108437 A MY108437 A MY 108437A
Authority
MY
Malaysia
Prior art keywords
paf
antagonists
imidazopyridine
formula
ring
Prior art date
Application number
MYPI92000223A
Other languages
English (en)
Inventor
Robert John Dr Bass
David Dr Alker
Kelvin Dr Cooper
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MY108437A publication Critical patent/MY108437A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Prostheses (AREA)
MYPI92000223A 1991-02-13 1992-02-12 Imidazopyridine paf/h1 antagonists MY108437A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919102997A GB9102997D0 (en) 1991-02-13 1991-02-13 Therapeutic agents

Publications (1)

Publication Number Publication Date
MY108437A true MY108437A (en) 1996-09-30

Family

ID=10689943

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI92000223A MY108437A (en) 1991-02-13 1992-02-12 Imidazopyridine paf/h1 antagonists

Country Status (29)

Country Link
US (1) US5358953A (enExample)
EP (1) EP0572425B1 (enExample)
JP (1) JP2506541B2 (enExample)
KR (1) KR970005302B1 (enExample)
CN (1) CN1040326C (enExample)
AT (1) ATE109482T1 (enExample)
AU (1) AU650322B2 (enExample)
BR (1) BR9205615A (enExample)
CA (1) CA2099381C (enExample)
CZ (1) CZ280504B6 (enExample)
DE (1) DE69200304T2 (enExample)
DK (1) DK0572425T3 (enExample)
EG (1) EG20085A (enExample)
ES (1) ES2059212T3 (enExample)
FI (1) FI933531A7 (enExample)
GB (1) GB9102997D0 (enExample)
HU (2) HUT65947A (enExample)
IE (1) IE65125B1 (enExample)
IL (1) IL100887A (enExample)
MX (1) MX9200589A (enExample)
MY (1) MY108437A (enExample)
NO (1) NO300592B1 (enExample)
NZ (1) NZ241597A (enExample)
PL (1) PL169304B1 (enExample)
RU (1) RU2114845C1 (enExample)
TW (1) TW227000B (enExample)
WO (1) WO1992014734A1 (enExample)
YU (1) YU48238B (enExample)
ZA (1) ZA921005B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
EP0775139A1 (en) * 1994-08-10 1997-05-28 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives as dual histamine (h1) and platelet activating factor (paf) antagonists
ES2087038B1 (es) * 1994-11-07 1997-03-16 Uriach & Cia Sa J Nuevas piperidinas con actividad antagonista del paf.
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
GB9508748D0 (en) * 1995-04-28 1995-06-14 British Biotech Pharm Benzimidazole derivatives
BR9609892A (pt) * 1995-08-05 1999-05-25 British Biotech Pharm Derivados de imidazopiridina
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
PT1311269E (pt) 2000-08-04 2012-05-10 Dmi Biosciences Inc Método de utilização de dicetopiperazinas e composição que contém as mesmas
ES2575563T3 (es) 2003-05-15 2016-06-29 Ampio Pharmaceuticals, Inc. Tratamiento de enfermedades mediadas por los linfocitos T
US7687515B2 (en) * 2006-01-17 2010-03-30 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
BRPI0821909A2 (pt) 2008-01-30 2018-07-17 Nippon Zoki Pharmaceutical Co., Ltd. derivado de piperidina
EP2300011A4 (en) 2008-05-27 2012-06-20 Dmi Life Sciences Inc THERAPEUTIC PROCESSES AND COMPOUNDS
JP5978296B2 (ja) * 2011-06-28 2016-08-24 フジアン・ミンドン・レジュヴネイション・ファーマスーティカル・カンパニー・リミテッド 抗アレルギ性ベンゾシクロヘプタチオフェン誘導体
SG10201608087WA (en) 2011-10-10 2016-11-29 Ampio Pharmaceuticals Inc Implantable medical devices with increased immune tolerance, and methods for making and implanting
SG10201608103YA (en) 2011-10-10 2016-11-29 Ampio Pharmaceuticals Inc Treatment of degenerative joint disease
CA2846394A1 (en) * 2011-10-28 2013-05-02 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
WO2014145729A2 (en) 2013-03-15 2014-09-18 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
EP3183240A4 (en) 2014-08-18 2018-06-27 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
HK1246669A1 (zh) 2015-06-22 2018-09-14 Ampio Pharmaceuticals, Inc. 人血清白蛋白低分子量组分在疾病治疗中的应用
CN113880801A (zh) * 2020-07-03 2022-01-04 合肥医工医药股份有限公司 一类三环化合物、其制备方法及其医药用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (enExample) * 1963-04-24
WO1989008653A1 (en) * 1988-03-15 1989-09-21 G.D. Searle & Co. 1H/3H-[4-(N,N-DICYCLOALKYL/BRANCHED-ALKYLCARBOXAMIDO)-BENZYL]IMIDAZO[4,5-c]PYRIDINES AS PAF ANTAGONISTS
NZ228889A (en) * 1988-04-28 1991-09-25 Schering Corp Fused tri- or tetracyclic heterocyclic compounds and pharmaceutical compositions
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5114919A (en) * 1990-02-26 1992-05-19 Merck & Co., Inc. Adjuncts in cancer chemotherapy
AU642265B2 (en) * 1990-05-09 1993-10-14 Pfizer Inc. Imidazo (4,5-c) pyridines with PAF antagonist activity

Also Published As

Publication number Publication date
IL100887A (en) 1996-01-19
ES2059212T3 (es) 1994-11-01
AU1168392A (en) 1992-09-15
FI933531A0 (fi) 1993-08-10
NO932889L (no) 1993-08-13
YU48238B (sh) 1997-08-22
IL100887A0 (en) 1992-11-15
CA2099381A1 (en) 1992-08-14
BR9205615A (pt) 1994-05-17
PL169304B1 (pl) 1996-06-28
CA2099381C (en) 1996-07-09
RU2114845C1 (ru) 1998-07-10
FI933531L (fi) 1993-08-10
WO1992014734A1 (en) 1992-09-03
ATE109482T1 (de) 1994-08-15
AU650322B2 (en) 1994-06-16
TW227000B (enExample) 1994-07-21
CS42592A3 (en) 1992-09-16
JP2506541B2 (ja) 1996-06-12
HU9302327D0 (en) 1993-10-28
GB9102997D0 (en) 1991-03-27
FI933531A7 (fi) 1993-08-10
DE69200304T2 (de) 1994-12-08
DK0572425T3 (da) 1994-09-12
ZA921005B (en) 1993-08-12
HU211202A9 (en) 1995-11-28
IE65125B1 (en) 1995-10-04
NZ241597A (en) 1993-04-28
EP0572425A1 (en) 1993-12-08
NO300592B1 (no) 1997-06-23
CN1064275A (zh) 1992-09-09
DE69200304D1 (de) 1994-09-08
EP0572425B1 (en) 1994-08-03
US5358953A (en) 1994-10-25
IE920449A1 (en) 1992-08-12
JPH06504992A (ja) 1994-06-09
CN1040326C (zh) 1998-10-21
HUT65947A (en) 1994-08-29
EG20085A (en) 1997-05-31
CZ280504B6 (cs) 1996-02-14
KR970005302B1 (ko) 1997-04-15
YU14392A (sh) 1994-11-15
NO932889D0 (no) 1993-08-13
MX9200589A (es) 1992-10-01

Similar Documents

Publication Publication Date Title
MY108437A (en) Imidazopyridine paf/h1 antagonists
YU82304A (sh) Kristalni 3,4,4-trisupstituisani-piperidinil-n-alkilkarboksilati, intermedijeri i postupak za dobijanje
ES2167371T3 (es) Derivados de 1h-3-aril-pirrolidin-2,4-diona espirociclicos substituidos.
ATE233559T1 (de) Verwendung von benzothiophene zur behandlung von hypercholesterolämie
ES2062064T3 (es) Derivados de (hidroxi-1 piperidinil-2 alquil)indolonas-2, quinoleinas-2, benzo(b)acepinonas-2, bencimidaizonas-2 y quinazolinonas-2, su preparacion y su aplicacion en terapeutica.
IL69912A (en) Substituted 1-hydroxyethyltriazolyl derivatives,their preparation and their use as plant protection agents
GR3005072T3 (enExample)
AR247744A1 (es) Compuestos organosilano y catalizadores que contienen dichos compuestos
DE3269272D1 (en) Organopolysiloxanes and their use as anti-foaming agents in aqueous dispersions and solutions of synthetic resins
DK0510003T3 (da) Piperidin-og pyrrolidinderivater
NO164351C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-alkyl-l-fenyl-2-piperazinoalkylpyrazolin-3-on-forbindelser.
ES8303375A1 (es) Procedimiento para la fabricacion de derivados 2 substitui- dos del feniltiazol.
YU46589B (sh) Smeše kaučuka koje se mogu vulkanizovati
JPS5430184A (en) 3,4-dihydrocarbostyril derivative
AU564799B2 (en) Composition for prophylactic and preventative of ketosis in livestock
TW225989B (enExample)
PH30229A (en) Pyridyl substituted benzothiazole compounds which has useful pharmaceutical utility
ES2062568T3 (es) Nuevos derivados de benzo (b) fenantrolinas-1,7 su preparacion y su aplicacion en terapeutica.
IE830686L (en) 1,2,5-thiadiazoles
IL62226A0 (en) Cephalosporins,their preparation and pharmaceutical compositions containing them
PT100223A (pt) Processo para a preparacao de imidazopiridinas antagonistas de paf/h1
JPS5424882A (en) Novel heterocyclic compounds and their preparation
FI973558L (fi) Menetelmä terapeuttisesti käytt¦kelpoisten 2-metyyli-imidatsoÄ4,5-cÜpyrid-1-yylijohdannaisten valmistamiseksi
MY103521A (en) Bicyclocatechol derivatives
IL67564A (en) 7-heteroaryl-(1,2)-fused 1,4-benzodiazepine compounds,their preparation and pharmaceutical compositions containing them